Treatment of Metastatic Melanoma With Leptomeningeal Disease Using Intrathecal Immunotherapy
JCO Oncol Pract
.
2020 Nov;16(11):757-759.
doi: 10.1200/OP.20.00146.
Epub 2020 Jun 30.
Authors
Laura A Huppert
1
,
Michelle E Melisko
1
,
Christine M Glastonbury
2
,
Elham Khanafshar
3
,
Adil I Daud
1
Affiliations
1
Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.
2
Division of Neuroradiology, Department of Radiology, University of California San Francisco, San Francisco, CA.
3
Department of Pathology, University of California San Francisco, San Francisco, CA.
PMID:
32603255
DOI:
10.1200/OP.20.00146
No abstract available
MeSH terms
Humans
Immunotherapy
Melanoma* / drug therapy
Meningeal Neoplasms*
Neoplasms, Second Primary*